Publication

Early-life febrile seizures worsen adult phenotypes in Scn1a mutants

Downloadable Content

Persistent URL
Last modified
  • 05/15/2025
Type of Material
Authors
    Stacey B. B. Dutton, Emory UniversityKaroni Dutt, University of California IrvineLigia A. Papale, Emory UniversitySandra Helmers, Emory UniversityAlan L. Goldin, University of California IrvineAndrew Escayg, Emory University
Language
  • English
Date
  • 2017-07-01
Publisher
  • Elsevier: 12 months
Publication Version
Copyright Statement
  • © 2017 Elsevier Inc.
License
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0014-4886
Volume
  • 293
Start Page
  • 159
End Page
  • 171
Grant/Funding Information
  • This research was supported by grants from NIH to AE (NS072221), ALG (NS048336), AE/ALG (NS065187) and an NIH/NIGMS IRACDA grant to SD (K12 GM000680).
Supplemental Material (URL)
Abstract
  • Mutations in the voltage-gated sodium channel (VGSC) gene SCN1A, encoding the Nav1.1 channel, are responsible for a number of epilepsy disorders including genetic epilepsy with febrile seizures plus (GEFS+) and Dravet syndrome (DS). Patients with SCN1A mutations often experience prolonged early-life febrile seizures (FSs), raising the possibility that these events may influence epileptogenesis and lead to more severe adult phenotypes. To test this hypothesis, we subjected 21–23-day-old mice expressing the human SCN1A GEFS+ mutation R1648H to prolonged hyperthermia, and then examined seizure and behavioral phenotypes during adulthood. We found that early-life FSs resulted in lower latencies to induced seizures, increased severity of spontaneous seizures, hyperactivity, and impairments in social behavior and recognition memory during adulthood. Biophysical analysis of brain slice preparations revealed an increase in epileptiform activity in CA3 pyramidal neurons along with increased action potential firing, providing a mechanistic basis for the observed worsening of adult phenotypes. These findings demonstrate the long-term negative impact of early-life FSs on disease outcomes. This has important implications for the clinical management of this patient population and highlights the need for therapeutic interventions that could ameliorate disease progression.
Author Notes
  • Corresponding Author: Andrew Escayg, Ph.D. Emory University, Department of Human Genetics, 615 Michael Street, Whitehead Building, Suite 301, Atlanta, Georgia 30322, USA, Telephone number: (404) 712-8328, Fax number: (404) 727-3949, aescayg@emory.edu
Keywords
Research Categories
  • Biology, General
  • Biology, Microbiology

Tools

Relations

In Collection:

Items